ReShape beefs up with $20M to bust fat
ReShape Medical, maker of a non-surgical device said to treat obesity, just reeled in $20 million in second-round funding to launch a trial of its lead product. Based in San Clemente, Calif., the company’s actual technology remains fairly stealthy.
The investment came from US Venture Partners, New Leaf Venture Partners and SV Life Sciences. Previously, ReShape raised $7.5 million over the course of 2006 and 2007. It has eight employees.
Life sciences briefing: Wednesday, Sept. 5, 2007
Featured companies: Atritech, Avalon Partners, Ensemble Discovery, Hyperion Therapeutics, LifeBond, ReShape Medical, SafeStitch, Trophos, UltraShape
Hyperion Therapeutics raises $40M against GI and kidney disease — Hyperion Therapeutics, a South San Francisco, Calif., specialty pharmaceutical company, raised $40 million in a second funding round. Investors included Sofinnova Ventures, Highland Capital Partners, New Enterprise Associates and WRF Capital.
Hyperion, which buys the rights to test and market drug candidates from other companies, said the proceeds will allow it to complete… Continue Reading